Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetes.
about
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic AgentsAn overview of the effect of sodium glucose cotransporter 2 inhibitor monotherapy on glycemic and other clinical laboratory parameters in type 2 diabetes patientsEffect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients.The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes.Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes.Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male MiceNew medical treatment strategies for nonalcoholic steatohepatitis.Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.
P2860
Q28074843-07ABC71D-757F-4CC4-9228-7A31170F2803Q37114983-D1BE9E17-56E0-40FC-B93F-09B939A88D51Q38762808-42D9B671-8C1A-442F-AE2C-E9AE599EF391Q38908779-E5787838-1DB7-40BB-8FD8-040C31383F39Q38936746-3EB88985-F6DB-4809-B74F-206D695BEAAEQ42107886-28082497-B1BB-43BF-9ABF-DA0BC3344438Q42175498-7C1573C0-9C4D-42C1-8EC0-AF3E05108CDAQ51291939-44A6A8B3-BBC6-4EBB-A4BB-3A8CE12DB00D
P2860
Randomized efficacy and safety trial of once-daily remogliflozin etabonate for the treatment of type 2 diabetes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@ast
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@en
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@nl
type
label
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@ast
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@en
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@nl
prefLabel
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@ast
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@en
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Randomized efficacy and safety ...... treatment of type 2 diabetes.
@en
P2093
R O'Connor-Semmes
S R Almond
W O Wilkison
P2860
P304
P356
10.1111/DOM.12393
P577
2014-11-03T00:00:00Z